These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 26519556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL, Grayson B, Idris NF, Lesage AS, Pemberton DJ, Mackie C, Neill JC.
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia.
    Miyauchi M, Neugebauer NM, Meltzer HY.
    J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
    [Abstract] [Full Text] [Related]

  • 4. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Horiguchi M, Miyauchi M, Neugebauer NM, Oyamada Y, Meltzer HY.
    Behav Brain Res; 2016 Mar 15; 301():132-41. PubMed ID: 26342283
    [Abstract] [Full Text] [Related]

  • 5. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB, McMahon LR.
    Psychopharmacology (Berl); 2017 Mar 15; 234(5):781-792. PubMed ID: 28028600
    [Abstract] [Full Text] [Related]

  • 6. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
    Rajagopal L, Kwon S, Huang M, Michael E, Bhat L, Cantillon M, Meltzer HY.
    Behav Brain Res; 2017 Aug 14; 332():180-199. PubMed ID: 28373127
    [Abstract] [Full Text] [Related]

  • 7. 5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA.
    Huang M, Kwon S, Rajagopal L, He W, Meltzer HY.
    Psychopharmacology (Berl); 2018 Oct 14; 235(10):2795-2808. PubMed ID: 30066135
    [Abstract] [Full Text] [Related]

  • 8. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
    Miyauchi M, Neugebauer NM, Sato T, Ardehali H, Meltzer HY.
    J Psychopharmacol; 2017 Dec 14; 31(12):1588-1604. PubMed ID: 28946779
    [Abstract] [Full Text] [Related]

  • 9. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
    Arunrungvichian K, Boonyarat C, Fokin VV, Taylor P, Vajragupta O.
    ACS Chem Neurosci; 2015 Aug 19; 6(8):1331-40. PubMed ID: 25978789
    [Abstract] [Full Text] [Related]

  • 10. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
    Hajós M, Hurst RS, Hoffmann WE, Krause M, Wall TM, Higdon NR, Groppi VE.
    J Pharmacol Exp Ther; 2005 Mar 19; 312(3):1213-22. PubMed ID: 15523001
    [Abstract] [Full Text] [Related]

  • 11. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction.
    Rajagopal L, Soni D, Meltzer HY.
    Behav Brain Res; 2018 Sep 17; 350():31-43. PubMed ID: 29763637
    [Abstract] [Full Text] [Related]

  • 12. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A.
    J Psychopharmacol; 2018 Dec 03; 33(1):269881118812097. PubMed ID: 30501536
    [Abstract] [Full Text] [Related]

  • 13. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ, Jones IW, Pullar IA, Wonnacott S.
    Neuropharmacology; 2005 Jul 03; 49(1):59-72. PubMed ID: 15992581
    [Abstract] [Full Text] [Related]

  • 14. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D, Bellucci C, Dei S, Teodori E, Varani K, Spirova E, Kudryavtsev D, Shelukhina I, Tsetlin V, Romanelli MN.
    Eur J Med Chem; 2016 Mar 03; 110():246-58. PubMed ID: 26840365
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.
    Iwamoto K, Mata D, Linn DM, Linn CL.
    Neuroscience; 2013 May 01; 237():184-98. PubMed ID: 23402849
    [Abstract] [Full Text] [Related]

  • 16. Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat.
    Wadenberg MG, Manetti D, Romanelli MN, Arias HR.
    Behav Brain Res; 2017 Aug 30; 333():129-134. PubMed ID: 28684359
    [Abstract] [Full Text] [Related]

  • 17. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
    Meltzer HY, Rajagopal L, Huang M, Oyamada Y, Kwon S, Horiguchi M.
    Int J Neuropsychopharmacol; 2013 Nov 30; 16(10):2181-94. PubMed ID: 24099265
    [Abstract] [Full Text] [Related]

  • 18. Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.
    Pandya AA, Yakel JL.
    Neuropharmacology; 2013 Jul 30; 70():35-42. PubMed ID: 23321689
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement.
    Huang M, Kwon S, Oyamada Y, Rajagopal L, Miyauchi M, Meltzer HY.
    Pharmacol Biochem Behav; 2015 Nov 30; 138():49-57. PubMed ID: 26383990
    [Abstract] [Full Text] [Related]

  • 20. Neurochemical arguments for the use of dopamine D4 receptor stimulation to improve cognitive impairment associated with schizophrenia.
    Huang M, Kwon S, He W, Meltzer HY.
    Pharmacol Biochem Behav; 2017 Jun 30; 157():16-23. PubMed ID: 28455126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.